Eli Lilly, AbCellera understanding to extinguish coronavirus therapy – Alternate Insider
Eli Lilly is joining many of its drug industry peers in the hunt for an effective coronavirus treatment. The $120 billion pharmaceutical giant finalized a collaboration with AbCellera, a private Canadian life sciences company, on Thursday. The goal is to s…